Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06623929
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-12
Brief Title:
Topical Treatments for Ankle Sprains
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Topical Analgesia Treatments for Ankle Sprains
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our aim was to evaluate the effects of topical analgesic drugs on rapid recovery of joint functions and pain relief in acute ankle injuries
A total of 100 patients were included in the study and divided into 2 groups as Diclofenac and Etofenamate The pain scores of the patients were evaluated with the Numeric Rating scale and Wong-Baker scale before and after treatment Dorsiflexion and plantarflexion active joint movements were measured with a hand-held goniometer for joint function before and after treatment
We found that ankle sprains were more common in men In our study we found that both topical analgesics were effective in improving joint movements and reducing pain
A total of 100 patients were included in the study and divided into 2 groups as Diclofenac and Etofenamate The pain scores of the patients were evaluated with the Numeric Rating scale and Wong-Baker scale before and after treatment Dorsiflexion and plantarflexion active joint movements were measured with a hand-held goniometer for joint function before and after treatment
We found that ankle sprains were more common in men In our study we found that both topical analgesics were effective in improving joint movements and reducing pain
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None